{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,3]],"date-time":"2026-02-03T18:17:58Z","timestamp":1770142678120,"version":"3.49.0"},"reference-count":34,"publisher":"Public Library of Science (PLoS)","issue":"5","license":[{"start":{"date-parts":[[2024,5,31]],"date-time":"2024-05-31T00:00:00Z","timestamp":1717113600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"abstract":"<jats:sec id=\"sec001\">\n<jats:title>Background<\/jats:title>\n<jats:p>Misoprostol treatment for early pregnancy loss has varied success demonstrated in previous studies. Incorporating predictors in a single clinical scoring system would be highly beneficial in clinical practice.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec002\">\n<jats:title>Objective<\/jats:title>\n<jats:p>To develop and evaluate the accuracy of a scoring system to predict misoprostol treatment outcomes for managing early pregnancy loss.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec003\">\n<jats:title>Study design<\/jats:title>\n<jats:p>Retrospective cohort and validation study.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec004\">\n<jats:title>Methods<\/jats:title>\n<jats:p>Patients discharged from the gynecologic emergency department from 2013 to 2016, diagnosed with early pregnancy loss, who were treated with 800 mcg misoprostol, administrated vaginally were included. All were sonographically reevaluated within 48\u201372 hours. Patients in whom the gestational sac was not expelled or with endometrial lining &gt;30 mm were offered a repeat dose and returned for reevaluation after seven days. A successful response was defined as complete expulsion. Clinical data were reviewed to identify predictors for successful responses. The scoring system was then retrospectively evaluated on a second cohort to evaluate its accuracy. Multivariate logistic regression was performed to identify factors most predictive of treatment response.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec005\">\n<jats:title>Results<\/jats:title>\n<jats:p>The development cohort included 126 patients. Six factors were found to be most predictive of misoprostol treatment effectiveness: nulliparity, prior complete spontaneous abortion, gestational age, vaginal bleeding, abdominal pain, and mean sac diameter, yielding a score of 0\u20138 (the MISOPRED score), where 8 represents the highest-likelihood of success. The score was validated retrospectively with 119 participants. Successful response in the group with the lowest likelihood score (score 0\u20133) was 9%, compared with 82% in the highest likelihood score group (score 7\u20138). Using the MISOPRED score, approximately 15% of patients previously planned to receive misoprostol treatment can be referred for surgical management.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec006\">\n<jats:title>Conclusions<\/jats:title>\n<jats:p>MISOPRED score can be utilized as an adjunct tool for clinical decision-making in cases of Early pregnancy loss. To our knowledge, this is the first scoring system suggested to predict the success rate in these cases.<\/jats:p>\n<\/jats:sec>","DOI":"10.1371\/journal.pone.0303607","type":"journal-article","created":{"date-parts":[[2024,5,31]],"date-time":"2024-05-31T18:58:14Z","timestamp":1717181894000},"page":"e0303607","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":1,"title":["The MISOPRED score: Development and validation of a clinical scoring system to predict the effectiveness of Misoprostol treatment for early pregnancy loss"],"prefix":"10.1371","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4605-5552","authenticated-orcid":true,"given":"Tomer","family":"Bar-Noy","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ofer","family":"Limonad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9197-645X","authenticated-orcid":true,"given":"Erika","family":"Gandelsman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alon","family":"Shrim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hila","family":"Sharabi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raphy","family":"Zarecki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mordechai","family":"Hallak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ilan","family":"Bruchim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2024,5,31]]},"reference":[{"issue":"22","key":"pone.0303607.ref001","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1056\/NEJM198812013192214","article-title":"Incidence of Early Loss of Pregnancy","volume":"319","author":"A Wilcox","year":"1988","journal-title":"N Engl J Med"},{"issue":"5","key":"pone.0303607.ref002","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1053\/beog.2000.0123","article-title":"Epidemiology and the medical causes of miscarriage.","volume":"14","author":"L Regan","year":"2000","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"key":"pone.0303607.ref003","doi-asserted-by":"crossref","unstructured":"ACOG Practice Bulletin No. 200: Early Pregnancy Loss. Obstet Gynecol. 2018;132(5):e197-e207. doi: 10.1097\/AOG.0000000000002899","DOI":"10.1097\/AOG.0000000000002899"},{"issue":"4","key":"pone.0303607.ref004","doi-asserted-by":"crossref","first-page":"e31","DOI":"10.1097\/AOG.0000000000004082","article-title":"Medication Abortion Up to 70 Days of Gestation: ACOG Practice Bulletin, Number 225.","volume":"136","author":"American College of Obstetricians and Gynecologists\u2019 Committee on Practice Bulletins\u2014Gynecology, Society of Family Planning","year":"2020","journal-title":"Obstet Gynecol"},{"issue":"1","key":"pone.0303607.ref005","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.contraception.2006.02.012","article-title":"Women\u2019s perceptions on medical abortion.","volume":"74","author":"PC Ho","year":"2006","journal-title":"Contraception."},{"issue":"11","key":"pone.0303607.ref006","article-title":"Medical methods for first trimester abortion.","volume":"2011","author":"R Kulier","year":"2011","journal-title":"Cochrane database Syst Rev."},{"issue":"6","key":"pone.0303607.ref007","article-title":"Medical treatment for early fetal death (less than 24 weeks).","volume":"2019","author":"M Lemmers","year":"2019","journal-title":"Cochrane Database Syst Rev"},{"key":"pone.0303607.ref008","doi-asserted-by":"crossref","unstructured":"ACOG Committee Opinion No. 427: Misoprostol for Postabortion Care. Obstet Gynecol. 2009;113(2, Part 1):465\u2013468. doi: 10.1097\/AOG.0b013e31819930f9","DOI":"10.1097\/AOG.0b013e31819930f9"},{"issue":"3","key":"pone.0303607.ref009","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.ijgo.2004.04.038","article-title":"Management of early pregnancy loss.","volume":"86","author":"GCM Graziosi","year":"2004","journal-title":"Int J Gynecol Obstet"},{"issue":"5","key":"pone.0303607.ref010","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1016\/j.ajog.2004.02.028","article-title":"Misoprostol for uterine evacuation in patients with early pregnancy failures.","volume":"190","author":"A Murchison","year":"2004","journal-title":"Am J Obstet Gynecol"},{"issue":"4","key":"pone.0303607.ref011","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1016\/j.fertnstert.2005.04.032","article-title":"Influence of clinical and ultrasound factors on the efficacy of misoprostol in first trimester pregnancy failure","volume":"84","author":"A Agostini","year":"2005","journal-title":"Fertil Steril"},{"issue":"6","key":"pone.0303607.ref012","first-page":"325","article-title":"Early pregnancy failure: factors affecting successful medical treatment.","volume":"12","author":"M Odeh","year":"2010","journal-title":"Isr Med Assoc J"},{"issue":"4","key":"pone.0303607.ref013","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/j.ajog.2020.04.006","article-title":"Management of early pregnancy loss with mifepristone and misoprostol: clinical predictors of treatment success from a randomized trial.","volume":"223","author":"S Sonalkar","year":"2020","journal-title":"Am J Obstet Gynecol"},{"issue":"5","key":"pone.0303607.ref014","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/S0010-7824(01)00205-0","article-title":"Serum beta-human chorionic gonadotropin levels and endometrial thickness after medical abortion.","volume":"63","author":"B Harwood","year":"2001","journal-title":"Contraception"},{"issue":"1","key":"pone.0303607.ref015","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.ijgo.2004.02.004","article-title":"Endometrial thickness after misoprostol use for early pregnancy failure.","volume":"86","author":"M. Creinin","year":"2004","journal-title":"Int J Gynecol Obstet"},{"issue":"5","key":"pone.0303607.ref016","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1097\/01.AOG.0000465191.27155.25","article-title":"Practice Bulletin No. 150","volume":"125","year":"2015","journal-title":"Obstet Gynecol"},{"issue":"10","key":"pone.0303607.ref017","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1002\/sim.1742","article-title":"Presentation of multivariate data for clinical use: The Framingham Study risk score functions.","volume":"23","author":"LM Sullivan","year":"2004","journal-title":"Stat Med"},{"issue":"29","key":"pone.0303607.ref018","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.1093\/eurheartj\/ehu207","article-title":"Towards better clinical prediction models: seven steps for development and an ABCD for validation","volume":"35","author":"EW Steyerberg","year":"2014","journal-title":"Eur Heart J"},{"issue":"1","key":"pone.0303607.ref019","doi-asserted-by":"crossref","first-page":"38","DOI":"10.3803\/EnM.2016.31.1.38","article-title":"How to Establish Clinical Prediction Models.","volume":"31","author":"Y ho Lee","year":"2016","journal-title":"Endocrinol Metab"},{"issue":"8","key":"pone.0303607.ref020","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1056\/NEJMoa044064","article-title":"A Comparison of Medical Management with Misoprostol and Surgical Management for Early Pregnancy Failure","volume":"353","author":"J Zhang","year":"2005","journal-title":"N Engl J Med"},{"key":"pone.0303607.ref021","doi-asserted-by":"crossref","first-page":"b604","DOI":"10.1136\/bmj.b604","article-title":"Prognosis and prognostic research: Developing a prognostic model","volume":"338","author":"P Royston","year":"2009","journal-title":"BMJ"},{"key":"pone.0303607.ref022","first-page":"338","article-title":"Prognosis and prognostic research: validating a prognostic model","author":"DG Altman","year":"2009","journal-title":"BMJ"},{"issue":"1","key":"pone.0303607.ref023","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1097\/EDE.0b013e3181c30fb2","article-title":"Assessing the Performance of Prediction Models.","volume":"21","author":"EW Steyerberg","year":"2010","journal-title":"Epidemiology"},{"issue":"1","key":"pone.0303607.ref024","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1080\/ejc.6.1.39.45","article-title":"Misoprostol for abortion at 9\u201312 weeks\u2019 gestation in adolescents.","volume":"6","author":"JL Carbonell","year":"2001","journal-title":"Eur J Contracept Reprod Health Care"},{"issue":"1","key":"pone.0303607.ref025","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1002\/uog.2654","article-title":"Transvaginal ultrasound after first\u2010trimester uterine evacuation reduces the incidence of retained products of conception.","volume":"27","author":"A Debby","year":"2006","journal-title":"Ultrasound Obstet Gynecol"},{"issue":"10","key":"pone.0303607.ref026","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1016\/S1701-2163(16)32966-8","article-title":"Endometrial Thickness and Serum \u03b2-hCG as Predictors of the Effectiveness of Oral Misoprostol in Early Pregnancy Failure.","volume":"30","author":"SMY El-Baradie","year":"2008","journal-title":"J Obstet Gynaecol Canada"},{"issue":"9","key":"pone.0303607.ref027","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.7863\/jum.2005.24.9.1181","article-title":"The Sonographic and Color Doppler Features of Retained Products of Conception","volume":"24","author":"SM Durfee","year":"2005","journal-title":"J Ultrasound Med"},{"issue":"5","key":"pone.0303607.ref028","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1002\/uog.5391","article-title":"Role of clinical and ultrasound findings in the diagnosis of retained products of conception.","volume":"32","author":"S Abbasi","year":"2008","journal-title":"Ultrasound Obstet Gynecol"},{"key":"pone.0303607.ref029","doi-asserted-by":"crossref","first-page":"110132","DOI":"10.1016\/j.contraception.2023.110132","article-title":"Effectiveness and safety of misoprostol-only for first-trimester medication abortion: An updated systematic review and meta-analysis.","volume":"127","author":"EG Raymond","year":"2023","journal-title":"Contraception."},{"issue":"1","key":"pone.0303607.ref030","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1097\/OGX.0000000000001222","article-title":"Combination of Mifepristone and Misoprostol for First-Trimester Medical Abortion: A Comprehensive Review of the Literature.","volume":"79","author":"V Kelesidou","year":"2024","journal-title":"Obstet Gynecol Surv."},{"issue":"12","key":"pone.0303607.ref031","doi-asserted-by":"crossref","first-page":"e808","DOI":"10.1055\/s-0043-1776029","article-title":"Efficacy, Safety, and Acceptability of Misoprostol in the Treatment of Incomplete Miscarriage: A Systematic Review and Meta-analysis.","volume":"45","author":"TMD Silva","year":"2023","journal-title":"Rev Bras Ginecol Obstet."},{"issue":"10","key":"pone.0303607.ref032","doi-asserted-by":"crossref","first-page":"2423","DOI":"10.4103\/jfmpc.jfmpc_503_23","article-title":"A prospective study on the effectiveness of a combination regime (Mifepristone and Misoprostol) in comparison with Misoprostol for missed abortion.","volume":"12","author":"N Gupta","year":"2023","journal-title":"J Family Med Prim Care"},{"issue":"4","key":"pone.0303607.ref033","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1097\/01.AOG.0000206737.68709.3e","article-title":"Factors Related to Successful Misoprostol Treatment for Early Pregnancy Failure.","volume":"107","author":"MD Creinin","year":"2006","journal-title":"Obstet Gynecol"},{"issue":"1","key":"pone.0303607.ref034","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/jep.12064","article-title":"A na\u00efve approach for deriving scoring systems to support clinical decision making.","volume":"20","author":"P Barbini","year":"2014","journal-title":"J Eval Clin Pract"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0303607","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,31]],"date-time":"2024-05-31T18:58:33Z","timestamp":1717181913000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0303607"}},"subtitle":[],"editor":[{"given":"Federico","family":"Ferrari","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2024,5,31]]},"references-count":34,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2024,5,31]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0303607","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,5,31]]}}}